Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / H•••••

S••••••••• H••••••••• Acquires H•••••, Expanding National Infusion Capabilities

Add-on acquisitionannouncedadd-onannounced Jun 16, 2026Fact
What happened
Platform
S••••••••• H•••••••••add-on basis: S••••••••• is backed by DFW Capital Partners, a New York-based investor focused on partnering with growth-oriented healthcare and business services companies.
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare, infusion
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
Side not stated
  • C•••• J•••Managementconfirmed
    “Today’s announcement represents an exciting step forward for S••••••••• H••••••••• and the patients and the provider partners we serve,” said C•••• J•••, chief executive officer of S••••••••• H•••••••••.
  • C•••• L••••Managementconfirmed
    “We are thrilled to join S••••••••• H••••••••• and continue advancing patient and physician peace of mind,” said C•••• L••••, chief operating officer of H•••••.
  • H•••••Targetconfirmed
    S••••••••• H••••••••• Acquires H•••••, Expanding National Infusion Capabilities
Evidence
S••••••••• H••••••••• Acquires H•••••, Expanding National Infusion Capabilities
S••••••••• H••••••••• Acquires H•••••, Expanding National Infusion Capabilities | Private Equity Intelligence | DFX